Akinobu Hamada Selected Research

Akinobu Hamada Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 02/2002
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2006
12	Breast Neoplasms (Breast Cancer) 04/2021 - 09/2007
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014 - 06/2009
5	Infections 01/2021 - 12/2004
5	Lung Neoplasms (Lung Cancer) 10/2017 - 02/2006
5	Acute Kidney Injury (Acute Renal Failure) 12/2011 - 04/2007
4	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2020 - 01/2012
4	Colorectal Neoplasms (Colorectal Cancer) 06/2009 - 08/2005
4	Prostatic Neoplasms (Prostate Cancer) 12/2008 - 08/2007
3	Diarrhea 04/2021 - 08/2005
3	Exanthema (Rash) 04/2021 - 01/2018
3	Adenocarcinoma of Lung 03/2019 - 02/2008
2	Anemia 04/2021 - 12/2004
2	Leukopenia 04/2021 - 08/2015
2	Erythema Multiforme 01/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2021 - 06/2011
2	Neoplasm Metastasis (Metastasis) 12/2020 - 06/2011
2	Triple Negative Breast Neoplasms 10/2019 - 01/2019
2	Brain Neoplasms (Brain Tumor) 07/2019 - 01/2015
2	Body Weight (Weight, Body) 08/2016 - 12/2011
2	Testicular Neoplasms (Testicular Cancer) 01/2015 - 01/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2015 - 01/2014
2	Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome) 08/2009 - 11/2005
2	Subacute Sclerosing Panencephalitis (SSPE) 10/2003 - 07/2003
1	Pneumonia (Pneumonitis) 10/2022
1	Chronic Renal Insufficiency 01/2022
1	Seizures (Absence Seizure) 11/2021
1	Glioma (Gliomas) 11/2021
1	Hypertension (High Blood Pressure) 04/2021
1	Alopecia (Baldness) 04/2021
1	Thrombocytopenia (Thrombopenia) 04/2021
1	Hypoalbuminemia 04/2021
1	Fatigue 04/2021
1	Constipation 04/2021
1	Cellulitis 04/2021
1	Nausea 04/2021
1	Lymphopenia (Lymphocytopenia) 04/2021
1	Fever (Fevers) 04/2021
1	Neutropenia 04/2021

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 01/2022 - 08/2005
12	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 06/2011
7	ErbB Receptors (EGF Receptor)IBA 01/2021 - 06/2011
6	Imatinib Mesylate (Gleevec)FDA Link 01/2014 - 04/2008
5	amrubicinIBA 01/2021 - 02/2006
5	EnzymesIBA 10/2019 - 04/2011
5	Peptides (Polypeptides)IBA 06/2016 - 08/2013
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2014
4	AntigensIBA 06/2016 - 08/2013
4	Carboplatin (JM8)FDA LinkGeneric 07/2015 - 12/2010
4	Proteins (Proteins, Gene)FDA Link 09/2013 - 02/2002
4	Cisplatin (Platino)FDA LinkGeneric 12/2011 - 04/2007
4	Irinotecan (Camptosar)FDA LinkGeneric 06/2009 - 08/2005
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2008 - 02/2002
3	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2015
3	eribulin FDA Link 10/2019 - 01/2019
3	Anaplastic Lymphoma KinaseIBA 03/2019 - 01/2018
3	CrizotinibIBA 03/2019 - 08/2016
3	Gemcitabine FDA Link 04/2018 - 01/2011
3	Complementary DNA (cDNA)IBA 06/2016 - 01/2014
3	EpitopesIBA 06/2016 - 08/2013
3	IndicanIBA 12/2011 - 04/2007
3	AndrogensIBA 12/2008 - 08/2007
3	amrubicinolIBA 02/2008 - 02/2006
3	Ribavirin (Virazole)FDA LinkGeneric 12/2004 - 07/2003
2	NivolumabIBA 01/2022 - 03/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Alanine Transaminase (SGPT)IBA 04/2021 - 01/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2021 - 01/2019
2	Docetaxel (Taxotere)FDA Link 04/2021 - 10/2016
2	AntibodiesIBA 01/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	TabletsIBA 10/2019 - 01/2019
2	olaparibIBA 10/2019 - 01/2019
2	Bevacizumab (Avastin)FDA Link 01/2019 - 12/2017
2	Monoclonal AntibodiesIBA 01/2018 - 10/2017
2	alectinibIBA 01/2018 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2017 - 01/2013
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2014 - 08/2013
2	nilotinib FDA Link 01/2014 - 01/2011
2	Gefitinib (Iressa)FDA Link 01/2014 - 06/2011
2	CationsIBA 12/2009 - 04/2008
2	Fluorouracil (Carac)FDA LinkGeneric 06/2009 - 09/2007
2	ProdrugsIBA 06/2009 - 09/2007
2	TegafurIBA 06/2009 - 09/2007
2	VA 061 (VA061)IBA 12/2008 - 08/2007
2	Testosterone (Sustanon)FDA Link 08/2008 - 06/2008
1	pembrolizumabIBA 10/2022
1	AfatinibIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	alpha-hydroxyglutarateIBA 11/2021
1	Glutamic Acid (Glutamate)FDA Link 11/2021
1	Guanosine Triphosphate (GTP)IBA 04/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 04/2021
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2021

Therapy/Procedure

20	Therapeutics 04/2021 - 07/2003
8	Drug Therapy (Chemotherapy) 01/2021 - 02/2006
6	Lasers (Laser) 01/2022 - 10/2017
2	Molecular Targeted Therapy 01/2022 - 01/2021
2	Immunotherapy 06/2016 - 01/2015